46 results
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:36pm
of the COVID-19 pandemic on our business;
general economic conditions; and
other risks and uncertainties described in this Quarterly Report on Form
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:35pm
of the COVID-19 pandemic on our business;
general economic conditions; and
other risks and uncertainties described in this Quarterly Report on Form
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:33pm
of the COVID-19 pandemic on our business;
general economic conditions; and
other risks and uncertainties described in this Quarterly Report on Form
8-K
EX-99.1
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
4:31pm
that the Company is unable to
secure regulatory approval for its product candidates; the effect of any resurgence of the COVID-19 pandemic or other public
8-K
EX-99.1
10lusk zk90
10 Aug 23
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
5:30pm
424B3
f9soq
10 Aug 23
Prospectus supplement
4:37pm
424B3
e33iusiz1dvb
10 Aug 23
Prospectus supplement
4:32pm
424B3
kyinx
10 Aug 23
Prospectus supplement
4:32pm
8-K
EX-99.1
jbn1t 8qh
1 Aug 23
Comera Life Sciences Announces $4.1 Million
4:08pm
424B3
k4i j8d28av5q
16 May 23
Prospectus supplement
4:33pm
424B3
vo6lhtjl8le5hl4ptoy
16 May 23
Prospectus supplement
4:31pm
424B3
kg901z
16 May 23
Prospectus supplement
4:31pm
8-K
EX-99.1
f8xfb502k8dapefz47yi
12 May 23
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
4:31pm
424B3
s57ii8
31 Mar 23
Prospectus supplement
4:34pm
424B3
smmhw3v aq4z7
31 Mar 23
Prospectus supplement
4:34pm
424B3
fcd ktzb4ha60
31 Mar 23
Prospectus supplement
4:32pm
424B3
r0zcczcnz5e45mq
14 Nov 22
Prospectus supplement
5:19pm